Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid.

Source:http://linkedlifedata.com/resource/pubmed/id/18459173

Cancer 2008 Jul 1 113 1 193-201

Download in:

View as

General Info

PMID
18459173